US Broker Ratings

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 31% Upside Potential

HealthStream, Inc. (NASDAQ: HSTM) offers investors a compelling opportunity in the healthcare sector, particularly within the burgeoning Health Information Services industry. With a market capitalization of..

SI-BONE, Inc. (SIBN) Stock Analysis: A Medical Device Innovator with 63% Upside Potential

SI-BONE, Inc. (NASDAQ: SIBN) is generating significant interest among investors in the healthcare sector, particularly in the medical devices industry. Headquartered in Santa Clara, California, SI-BONE..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with 84% Upside Potential

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, is drawing attention in the investment community with its promising pipeline targeting cystic fibrosis (CF). With a..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Potential 292% Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors with its significant potential upside, pegged at an impressive 292.33%. Operating within the healthcare sector..

Immunome, Inc. (IMNM) Stock Analysis: A 143.96% Potential Upside in the Biotech Sector

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors with its promising potential upside of 143.96%, as highlighted by recent analyst ratings. This clinical-stage biotechnology..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A Promising 18.95% Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Collegium Pharmaceutical, Inc. (NASDAQ: COLL) an appealing prospect, as recent analysis suggests a potential upside of nearly..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 65.87% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may find AxoGen, Inc. (NASDAQ: AXGN) to be an intriguing opportunity. As a leader in the niche field..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Closer Look at the 76.98% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector specializing in medical devices, is catching the eye of investors with its significant potential upside..

Owens & Minor, Inc. (OMI) Stock Analysis: Evaluating the 16% Upside Potential Amidst Challenging Metrics

Owens & Minor, Inc. (NYSE: OMI) finds itself at an intriguing juncture, presenting a complex mix of potential opportunity and caution for investors. As a key..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Visionary Biotech with a 24% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ) has emerged as a promising player in the biotechnology sector, focusing on a niche market with significant growth potential: the development..

CeriBell, Inc. (CBLL) Stock Analysis: Unpacking a 154% Potential Upside for this Medical Device Innovator

CeriBell, Inc. (NASDAQ: CBLL), a prominent player in the healthcare sector, particularly in medical devices, is making waves with its innovative approach to neurological care. Headquartered..

Nutex Health Inc. (NUTX) Stock Analysis: A Healthcare Growth Star with 123% Potential Upside

Nutex Health Inc. (NUTX) has emerged as a promising player in the healthcare sector, with its unique business model and impressive growth metrics capturing the attention..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a Potential 185.71% Upside in the Biotech Sector

Bicara Therapeutics Inc. (BCAX) is capturing the attention of investors with its promising potential for significant upside. This clinical-stage biopharmaceutical company, based in Boston, Massachusetts, focuses..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Examining the 11.87% Potential Upside for Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is making waves in the biotechnology sector, and for good reason. The Chicago-based commercial-stage biopharmaceutical company is focusing its efforts..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: A Promising 35% Upside Potential with Strong Buy Ratings

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is catching the attention of investors with its robust growth potential in the biopharmaceutical sector. Headquartered in Dublin, Ireland, Avadel specializes..

Taysha Gene Therapies (TSHA) Stock Analysis: A Biotech Player with 194.78% Potential Upside

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is making waves in the biotechnology sector with its innovative approach to gene therapies targeting central nervous system disorders. As..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Focus in the Healthcare Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, particularly within the medical devices industry, is navigating a complex landscape characterized by both..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Compelling 182% Potential Upside Amidst Biotech Innovation

For investors with a keen interest in the healthcare sector, particularly biotechnology, Nurix Therapeutics, Inc. (NRIX) presents an intriguing opportunity. With its market cap standing at..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 41.63% Upside Potential in the Healthcare Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is capturing the attention of investors with its pioneering advancements in medical devices, specifically targeting the diabetes market. As of its..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a Bold 155.70% Potential Upside

As investors seek opportunities within the ever-evolving biotechnology sector, Dianthus Therapeutics, Inc. (NASDAQ: DNTH) emerges as a noteworthy contender. This clinical-stage biotech firm, headquartered in New..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds